Alnylam Pharmaceuticals
ALNY
#601
Rank
HK$324.55 B
Marketcap
HK$2,432
Share price
0.70%
Change (1 day)
32.41%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company